157 related articles for article (PubMed ID: 38773747)
1. Guidelines for Manufacturing and Application of Organoids: Liver.
Moon HR; Mun SJ; Kim TH; Kim H; Kang D; Kim S; Shin JH; Choi D; Ahn SJ; Son MJ
Int J Stem Cells; 2024 May; 17(2):120-129. PubMed ID: 38773747
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for Manufacturing and Application of Organoids: Heart.
Lee HA; Woo DH; Lim DS; Oh J; Kim CY; Bae ON; Ahn SJ
Int J Stem Cells; 2024 May; 17(2):130-140. PubMed ID: 38777829
[TBL] [Abstract][Full Text] [Related]
3. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
4. Essential Guidelines for Manufacturing and Application of Organoids.
Ahn SJ; Lee S; Kwon D; Oh S; Park C; Jeon S; Lee JH; Kim TS; Oh IU
Int J Stem Cells; 2024 May; 17(2):102-112. PubMed ID: 38764240
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Acute Hepatotoxicity With Human Pluripotent Stem Cell-Derived Hepatic Organoids.
Kim H; Kim SK; Oelgeschläger M; Park HJ
Curr Protoc; 2024 Apr; 4(4):e1015. PubMed ID: 38597874
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Manufacturing and Application of Organoids: Skin.
Lee S; Rim YA; Kim J; Lee SH; Park HJ; Kim H; Ahn SJ; Ju JH
Int J Stem Cells; 2024 May; 17(2):182-193. PubMed ID: 38783680
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Manufacturing and Application of Organoids: Lung.
Lim K; Lee MO; Choi J; Kim JH; Kim EM; Woo CG; Chung C; Cho YH; Hong SH; Cho YJ; Ahn SJ
Int J Stem Cells; 2024 May; 17(2):147-157. PubMed ID: 38777828
[TBL] [Abstract][Full Text] [Related]
8. Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis.
Lee J; Jung S; Hong HK; Jo H; Rhee S; Jeong YL; Ko J; Cho YB; Jeon NL
Lab Chip; 2024 Apr; 24(8):2208-2223. PubMed ID: 38533822
[TBL] [Abstract][Full Text] [Related]
9. Toward reproducible tumor organoid culture: focusing on primary liver cancer.
Guo L; Li C; Gong W
Front Immunol; 2024; 15():1290504. PubMed ID: 38571961
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for Manufacturing and Application of Organoids: Brain.
Kwak T; Park SH; Lee S; Shin Y; Yoon KJ; Cho SW; Park JC; Yang SH; Cho H; Im HI; Ahn SJ; Sun W; Yang JH
Int J Stem Cells; 2024 May; 17(2):158-181. PubMed ID: 38777830
[TBL] [Abstract][Full Text] [Related]
11. Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation.
Nguyen HN
Methods Mol Biol; 2022; 2474():93-105. PubMed ID: 35294759
[TBL] [Abstract][Full Text] [Related]
12. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
13. Advances in liver organoids: model systems for liver disease.
Lee J; Mun SJ; Shin Y; Lee S; Son MJ
Arch Pharm Res; 2022 Jun; 45(6):390-400. PubMed ID: 35661984
[TBL] [Abstract][Full Text] [Related]
14. Assay establishment and validation of a high-throughput organoid-based drug screening platform.
Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G
Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149
[TBL] [Abstract][Full Text] [Related]
15. In Situ Detection of Kidney Organoid Generation From Stem Cells Using a Simple Electrochemical Method.
Suhito IR; Kim JW; Koo KM; Nam SA; Kim YK; Kim TH
Adv Sci (Weinh); 2022 Jul; 9(20):e2200074. PubMed ID: 35506260
[TBL] [Abstract][Full Text] [Related]
16. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment.
Brooks A; Liang X; Zhang Y; Zhao CX; Roberts MS; Wang H; Zhang L; Crawford DHG
Pharmacol Res; 2021 Jul; 169():105608. PubMed ID: 33852961
[TBL] [Abstract][Full Text] [Related]
17. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.
Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D
Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578
[TBL] [Abstract][Full Text] [Related]
18. Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation.
Choi SY; Kim TH; Kim MJ; Mun SJ; Kim TS; Jung KK; Oh IU; Oh JH; Son MJ; Lee JH
Toxics; 2024 May; 12(5):. PubMed ID: 38787150
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
Shiota J; Samuelson LC; Razumilava N
Hepatology; 2021 Oct; 74(4):2251-2263. PubMed ID: 33638203
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
Zhou Z; Cong L; Cong X
Front Oncol; 2021; 11():762184. PubMed ID: 35036354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
